# OnCo record plb-002 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/plb-002/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "plb-002" ;
  schema:name "PLB-002"@en ;
  schema:description "PLB-002 is an experimental antibody-drug conjugate from PrimeLink BioTherapeutics, in phase 1 trials for ovarian cancer, non-small cell lung cancer and CLDN6-positive solid tumours."@en ;
  schema:url <https://onco.cc/drugs/plb-002/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <http://en.primelinkbio.com/news_detail/13.html>, <http://en.primelinkbio.com/news_detail/13.html>, <https://www.primelinkbio.com/pipeline/1.html>, <https://clinicaltrials.gov/api/v2/studies/NCT07304128>, <https://clinicaltrials.gov/search?intr=PLB-002> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Antibody-drug conjugate" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:targets <https://onco.cc/targets/cldn6/> ;
  onco:companies <https://onco.cc/companies/primelink-biotherapeutics/> ;
  onco:trials <https://onco.cc/trials/nct07304128/> .